Related Experiment Video
Updated: Jan 26, 2026

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies
Raquel Yotti1,2, Christine E Seidman3,4,5, Jonathan G Seidman3
1Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain;
Insights
Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) stem from genetic variants affecting heart muscle proteins. New research reveals molecular mechanisms in HCM related to relaxation and energy conservation, and in DCM, titin variants impairing muscle development, paving the way for new treatments.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are prevalent heart muscle diseases.
- These conditions result from pathogenic variants in genes encoding sarcomere proteins.
- HCM involves unexplained cardiac hypertrophy with altered contractility and relaxation; DCM features enlarged ventricles and impaired function.
Purpose of the Study:
- To review recent analyses offering new insights into the molecular mechanisms underlying HCM and DCM.
- To highlight novel pathophysiologic mechanisms discovered for these cardiomyopathies.
- To identify potential new pharmacological targets and cardioprotective strategies.
Main Methods:
- Review of recent scientific analyses and studies on hypertrophic cardiomyopathy and dilated cardiomyopathy.
- Focus on molecular mechanisms, genetic variants, and their functional consequences.
- Analysis of findings related to sarcomere protein gene mutations.
Main Results:
- HCM studies emphasize the role of disturbed conformational changes during relaxation and energy conservation due to mutations.
- DCM studies reveal a high prevalence of truncating variants in titin.
- These titin variants impair contractile function by disrupting sarcomerogenesis.
Conclusions:
- Understanding these new pathophysiologic mechanisms is crucial for advancing cardiovascular medicine.
- Identified mechanisms provide opportunities for developing novel pharmacological therapies.
- Future cardioprotective strategies can be informed by these molecular insights into HCM and DCM.
Abstract:
Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are common heart muscle disorders that are caused by pathogenic variants in sarcomere protein genes. HCM is characterized by unexplained cardiac hypertrophy (increased chamber wall thickness) that is accompanied by enhanced cardiac contractility and impaired relaxation. DCM is defined as increased ventricular chamber volume with contractile impairment. In this review, we discuss recent analyses that provide new insights into the molecular mechanisms that cause these conditions. HCM studies have uncovered the critical importance of conformational changes that occur during relaxation and enable energy conservation, which are frequently disturbed by HCM mutations. DCM studies have demonstrated the considerable prevalence of truncating variants in titin and have discerned that these variants reduce contractile function by impairing sarcomerogenesis. These new pathophysiologic mechanisms open exciting opportunities to identify new pharmacological targets and develop future cardioprotective strategies.
More Related Videos
Related Concept Videos
The Sarcomere
Each...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

